3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Conditions
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Colorectal Neoplasms
2
Neoplasm Metastasis
1
NSCLC
1
Interventions
Bevacizumab
30
pembrolizumab
29
Oxaliplatin
28
Leucovorin
25
Fluorouracil
24
Irinotecan
22
Cetuximab
22
Capecitabine
19
Nivolumab
15
Specimen Handling
12
atezolizumab
11
Panitumumab
11
Colonoscopy
9
Carboplatin
9
regorafenib
8
Biopsy
8
trifluridine tipiracil drug combination
7
Trifluridine
7
Paclitaxel
7
Aspirin
7
balstilimab
6
Standard of Care
6
Cisplatin
6
tislelizumab
5
encorafenib
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Immunoglobulin G
5
Folfox protocol
5
Disulfides
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Colorectal Neoplasms
×
JDQ443
×
Clear all
NCT05358249
2026-04-14
KontRASt-03
Novartis
Phase 1/2
Active not recruiting
74 enrolled
NCT04699188
2026-03-18
KontRASt-01
Novartis
Phase 1/2
Active not recruiting
344 enrolled